Inhibition of Nuclear Receptor Binding SET Domain 2/ Multiple Myeloma SET Domain by LEM-06 Implication for Epigenetic Cancer Therapies

Abstract

We propose LEM-06 as a hit inhibitor that is useful to further optimize for exploring the biology of NSD2. LEM-06 derivatives may pave the way to specific NSD2 inhibitors suitable for therapeutic efforts against malignancies.